Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Finn

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 22, 2015
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disordersRebecca J Henry, Daniel M Kerr, David P Finn, et al.
Experimental Neurology|June 19, 2016
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's diseaseRuth M Concannon, Bright N Okine, David P Finn, et al.
Behavioural Brain Research|June 29, 2018
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female ratsLisa E Flannery, Daniel M Kerr, David P Finn, et al.
British Journal of Pharmacology|May 31, 2018
The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific mannerKieran Rea, Fiona McGowan, Louise Corcoran, et al.
Journal of Neuroscience Research|July 13, 2016
Psychological stress in early life as a predisposing factor for the development of chronic pain: Clinical and preclinical evidence and neurobiological mechanismsNikita N Burke, David P Finn, Brian E McGuire, et al.
Experimental Neurology|April 22, 2015
Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's diseaseRuth M Concannon, Bright N Okine, David P Finn, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 27, 2009
The effects of synthetic and endogenous imidazoline binding site ligands on neuronal activity in discrete brain regions of naive and restraint-stressed ratsKaren L Smith, Michelle Roche, David S Jessop, et al.
European Journal of Pain (London, England)|February 29, 2008
Investigating the effects of distracting stimuli on nociceptive behaviour and associated alterations in brain monoamines in ratsGemma K Ford, Orla Moriarty, Brian E McGuire, et al.
Journal of Neuroimmunology|September 24, 2014
FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampusRebecca J Henry, Daniel M Kerr, David P Finn, et al.
Psychopharmacology|December 18, 2007
Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regionsShirley A Hesketh, Adrian K Brennan, David S Jessop, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 22, 2015
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disordersRebecca J Henry, Daniel M Kerr, David P Finn, et al.
Experimental Neurology|June 19, 2016
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's diseaseRuth M Concannon, Bright N Okine, David P Finn, et al.
Behavioural Brain Research|June 29, 2018
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female ratsLisa E Flannery, Daniel M Kerr, David P Finn, et al.
British Journal of Pharmacology|May 31, 2018
The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific mannerKieran Rea, Fiona McGowan, Louise Corcoran, et al.
Journal of Neuroscience Research|July 13, 2016
Psychological stress in early life as a predisposing factor for the development of chronic pain: Clinical and preclinical evidence and neurobiological mechanismsNikita N Burke, David P Finn, Brian E McGuire, et al.
Experimental Neurology|April 22, 2015
Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's diseaseRuth M Concannon, Bright N Okine, David P Finn, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 27, 2009
The effects of synthetic and endogenous imidazoline binding site ligands on neuronal activity in discrete brain regions of naive and restraint-stressed ratsKaren L Smith, Michelle Roche, David S Jessop, et al.
European Journal of Pain (London, England)|February 29, 2008
Investigating the effects of distracting stimuli on nociceptive behaviour and associated alterations in brain monoamines in ratsGemma K Ford, Orla Moriarty, Brian E McGuire, et al.
Journal of Neuroimmunology|September 24, 2014
FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampusRebecca J Henry, Daniel M Kerr, David P Finn, et al.
Psychopharmacology|December 18, 2007
Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regionsShirley A Hesketh, Adrian K Brennan, David S Jessop, et al.
Pageof 16